Kathryn M. Curtis PhD, Aniket D. Kulkarni MBBS, MPH, Antoinette T. Nguyen MD, MPH, Lauren B. Zapata PhD, Katherine Kortsmit PhD, MPH, Ruben A. Smith PhD, Maura K. Whiteman PhD
{"title":"2019 年 1 月至 2020 年 9 月 COVID-19 大流行初期美国避孕服务商业保险索赔的变化。","authors":"Kathryn M. Curtis PhD, Aniket D. Kulkarni MBBS, MPH, Antoinette T. Nguyen MD, MPH, Lauren B. Zapata PhD, Katherine Kortsmit PhD, MPH, Ruben A. Smith PhD, Maura K. Whiteman PhD","doi":"10.1016/j.whi.2023.10.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p><span><span><span>We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and </span>injectable contraception and monthly rates of pharmacy claims for </span>contraceptive pills, patches, and rings. We used Joinpoint </span>regression analysis<span> to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.</span></p></div><div><h3>Results</h3><p>Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (<1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.</p></div><div><h3>Conclusions</h3><p><span>Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during </span>public health emergencies.</p></div>","PeriodicalId":48039,"journal":{"name":"Womens Health Issues","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020\",\"authors\":\"Kathryn M. Curtis PhD, Aniket D. Kulkarni MBBS, MPH, Antoinette T. Nguyen MD, MPH, Lauren B. Zapata PhD, Katherine Kortsmit PhD, MPH, Ruben A. Smith PhD, Maura K. Whiteman PhD\",\"doi\":\"10.1016/j.whi.2023.10.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.</p></div><div><h3>Methods</h3><p><span><span><span>We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and </span>injectable contraception and monthly rates of pharmacy claims for </span>contraceptive pills, patches, and rings. We used Joinpoint </span>regression analysis<span> to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.</span></p></div><div><h3>Results</h3><p>Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (<1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.</p></div><div><h3>Conclusions</h3><p><span>Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during </span>public health emergencies.</p></div>\",\"PeriodicalId\":48039,\"journal\":{\"name\":\"Womens Health Issues\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Womens Health Issues\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1049386723001858\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Womens Health Issues","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1049386723001858","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020
Objective
We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.
Methods
We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and injectable contraception and monthly rates of pharmacy claims for contraceptive pills, patches, and rings. We used Joinpoint regression analysis to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.
Results
Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (<1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.
Conclusions
Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during public health emergencies.
期刊介绍：
Women"s Health Issues (WHI) is a peer-reviewed, bimonthly, multidisciplinary journal that publishes research and review manuscripts related to women"s health care and policy. As the official journal of the Jacobs Institute of Women"s Health, it is dedicated to improving the health and health care of all women throughout the lifespan and in diverse communities. The journal seeks to inform health services researchers, health care and public health professionals, social scientists, policymakers, and others concerned with women"s health.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
